Modulation of Human Thrombopoietin Receptor Conformations Uncouples JAK2 V617F-Driven From Cytokine-Induced Activation.
Journal article
Papadopoulos N. et al, (2023), Blood
Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers.
Journal article
Defour J-P. et al, (2023), eLife, 12
Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology.
Journal article
Suelves N. et al, (2023), Acta neuropathologica communications, 11
Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation.
Journal article
Papadopoulos N. et al, (2023), Nature communications, 14
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Journal article
Matuozzo D. et al, (2023), Genome medicine, 15
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.
Journal article
Willekens C. et al, (2023), Leukemia
Innovations 2022 in the field of hemostasis-thrombosis
Journal article
Bailly S. et al, (2023), Louvain Medical, 142, 101 - 108
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Journal article
Pecquet C. et al, (2023), Blood, 141, 917 - 929
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis.
Journal article
Lecomte S. et al, (2023), Blood, 141, 490 - 502
Editorial: Recent advances in molecular and structural endocrinology.
Journal article
De Meyts P. and Constantinescu SN., (2023), Frontiers in endocrinology, 14
Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report.
Journal article
Gurban P. et al, (2023), Frontiers in oncology, 13
Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
Journal article
Havelange V. and Constantinescu SN., (2023), American Journal of Hematology
Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates.
Journal article
Papadopoulos N. et al, (2022), Biomedicines, 10
The 2 faces of ERK2 in MPNs.
Journal article
Havelange V. and Constantinescu SN., (2022), Blood, 140, 298 - 300
Studying severe long COVID to understand post-infectious disorders beyond COVID-19.
Journal article
Brodin P. et al, (2022), Nature medicine, 28, 879 - 882
JAK inhibitors and COVID-19.
Journal article
Levy G. et al, (2022), Journal for immunotherapy of cancer, 10
2021 Innovation in hematology
Journal article
Vekemans MC. et al, (2022), Louvain Medical, 141, 85 - 102
Human genetic and immunological determinants of critical COVID-19 pneumonia
Journal article
Zhang Q. et al, (2022), Nature
Degrading JAK2 in ALL by ruxolitinib-based PROTACs
Journal article
Constantinescu SN. and Pecquet C., (2021), Blood, 138, 2301 - 2302
MPL S505C enhances driver mutations at W515 in essential thrombocythemia.
Journal article
Varghese LN. et al, (2021), Blood cancer journal, 11